Articles: chronic.
-
Non-Invasive VentilationSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 12:15 PM - 01:15 PMPURPOSE: Evaluation of non invasive ventilation (NIV) instituted for the first time in hospitalizations of patients with exacerbation of chronic obstructive pulmonary disease (COPD) associated with acute hypercapnic respiratory failure (AHRF) and its prognosis. ⋯ The following authors have nothing to disclose: Maria João Oliveira, Margarida Dias, Inês Franco, Sara CondeNo Product/Research Disclosure Information.
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The objective of this study was to describe demographic and clinical characteristics of PEA-eligible patients including the cost and length of stay related to the surgery. ⋯ Vijay Joish: Employee: employee of Bayer healthcare David Muccino: Employee: Employee of Bayer Healthcare Naresh Rao: Consultant fee, speaker bureau, advisory committee, etc.: contract researcher paid by Bayer healthcareNo Product/Research Disclosure Information.
-
Bronchiectasis PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To evaluate the effects of treatment with inhaled tobramycin in patients with non-CF bronchiectasis (BQ) considering the eradication of Pseudomona aeruginosa in sputum, changes in sputum and lung function. ⋯ The following authors have nothing to disclose: Georgina Gramblicka, María Sosa, Gabriela Tabaj, María Gallardo, Valeria Morandi, Maria Laura Grodnitzky, Luciano Peyrano, Daniela Visentini, Patricia MalamudNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: The purpose of this study was to evaluated the effect of triple-combined long acting inhaled bronchodilator treatment with roflumilast and dual-combined long acting inhaled bronchodilator and single-long acting inhaled bronchodilator treatment on exacerbations in patients with severe and very severe chronic obstructive pulmonary disease(COPD). ⋯ The following authors have nothing to disclose: Alizamin Sadigov, Sakhavatdin Akhundov, Rovshan BagirovNo Product/Research Disclosure Information.
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Comorbidities with COPD (Chronic Obstructive Pulmonary Disease) is one of the most important problems. Previous reports suggested that systemic inflammation may be the link between COPD and comorbidities, but this issue is still low debated in Japan. Whatever the mechanism of comorbidities may be, it has important clinical, prognostic and therapeutic problems. In this study, investigated for the evaluation and measures about COPD burden patients of the current situation in rural area Japan. And also aimed that through comorbidities, contributes to improving patients care and COPD awareness. ⋯ The following authors have nothing to disclose: Tomoyasu UnoNo Product/Research Disclosure Information.